Translational Control of Immune Evasion in Cancer: Trends in Cancer

Por um escritor misterioso

Descrição

Translational Control of Immune Evasion in Cancer: Trends in Cancer
Obstacles for T-lymphocytes in the tumour microenvironment
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Gut microbiome in modulating immune checkpoint inhibitors
Translational Control of Immune Evasion in Cancer: Trends in Cancer
IFNγ-induced stem-like state of cancer cells as a driver of
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Gut Microbiota in Cancer Immune Response and Immunotherapy: Trends
Translational Control of Immune Evasion in Cancer: Trends in Cancer
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Frontiers Cancer Stem Cells: Emerging Key Players in Immune
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Epigenetic dysregulation of immune-related pathways in cancer
Translational Control of Immune Evasion in Cancer: Trends in Cancer
How to overcome resistance to immune checkpoint inhibitors in
Translational Control of Immune Evasion in Cancer: Trends in Cancer
Targeted Cancer Immunotherapy: Nanoformulation Engineering and
de por adulto (o preço varia de acordo com o tamanho do grupo)